Cancer cell membrane-modified Soluplus® micelles for gemcitabine delivery to pancreatic cancer using a prodrug approach

  1. Pereira-Silva, M.
  2. Diaz-Gomez, L.
  3. Blanco-Fernandez, B.
  4. Ferreirós, A.
  5. Veiga, F.
  6. Concheiro, A.
  7. Paiva-Santos, A.C.
  8. Alvarez-Lorenzo, C.
Journal:
International Journal of Pharmaceutics

ISSN: 1873-3476 0378-5173

Year of publication: 2024

Volume: 662

Type: Article

DOI: 10.1016/J.IJPHARM.2024.124529 GOOGLE SCHOLAR lock_openOpen access editor